JonathanMGreenMD
Pulmonology • Saint Louis, MOCritical Care Medicine, Pleural Disease
Professor, Internal Medicine, Washington University in St. Louis School of Medicine
Dr. Green is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
660 S Euclid Ave
Saint Louis, MO 63110Phone+1 314-454-8917Fax+1 314-362-8987
Education & Training
University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
Boston University Medical CenterResidency, Internal Medicine, 1986 - 1990
Wayne State University School of MedicineClass of 1986
Certifications & Licensure
MD State Medical License 2021 - 2026
MO State Medical License 1996 - 2025
IL State Medical License 1993 - 2008
MA State Medical License 1988 - 2007
MI State Medical License 1990 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics Start of enrollment: 2008 Oct 01
Publications & Presentations
PubMed
- 173 citationsA prospective analysis of lymphocyte phenotype and function over the course of acute sepsisJonathan S. Boomer, Jennifer Shuherk-Shaffer, Richard S. Hotchkiss, Jonathan M. Green
Critical Care. 2012-06-28 - 60 citationsInterleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.Yuichiro Shindo, Anja Fuchs, Christopher G. Davis, Tim Eitas, Jacqueline Unsinger
Journal of Leukocyte Biology. 2017-02-01 - 203 citationsThe changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?Jonathan S. Boomer, Jonathan M. Green, Richard S. Hotchkiss
Virulence. 2014-01-01
Grant Support
- Immunologic Basis For Susceptibility To Secondary Infections In Severe SepsisNational Heart, Lung, And Blood Institute2010–2011
- Costimulatory Molecules In Inflammatory Lung DiseaseNational Heart, Lung, And Blood Institute2005–2011
- Btla/Pd-1 Signaling And TH CellsNational Institute Of Allergy And Infectious Diseases2006–2010
- CD43: A Novel Regulator Of Lymphocyte AdhesionNational Heart, Lung, And Blood Institute2002–2006
- How CD2 And CD28 Determine Susceptibility To P. CariniiNational Institute Of Allergy And Infectious Diseases2002–2003
- Structural Basis Of CD28 Regulation Of Lung InflammationNational Heart, Lung, And Blood Institute2000–2003
- Mechanism Of CD43 Regulation Of Pulmonary InflammationNational Heart, Lung, And Blood Institute1998–2001
- T Cell Costimulation In Inflammatory Lung DiseaseNational Heart, Lung, And Blood Institute1996–2000
- Mechanism Of CD43 Regulation Of Pulmonary InflammationNational Heart, Lung, And Blood Institute1997
- CD28 And LFA-1 And T Cell ActivationNational Institute Of Allergy And Infectious Diseases1994
- Role Of CD28 And LFA-1 In T-Cell ActivationNational Institute Of Allergy And Infectious Diseases1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
